Exhibit 52 - Cal Yr 2023 City of Miami CIGNA Pooled Stop Loss High Claims Greater than 50K Experience De-ID.xlsx

XLSX spreadsheet 38 KB Posted Sep 30, 2025

Attached to: RFP No. 2130386 - Employee Health Benefits Plan
Solicitation number: RFP No. 2130386
Issued by: Florida

About this file

Written by GovTribe AI · Oct 1, 2025

This is a de-identified claims experience spreadsheet for the City of Miami's health insurance program for calendar year 2023, focusing on claims exceeding $50,000. The document provides detailed medical claims data for employees across different benefit options, including Network Open Access POS plans covering various employee categories such as active employees (general, SEA, M/C), executives/elected officials, and non-Medicare retirees.

The spreadsheet reveals comprehensive medical claim information, categorized by funding type, rating type, gender, age band, and specific ICD diagnostic codes. Each entry includes drug claims, paid claims, and total claim amounts for individual claimants, with diagnoses ranging from osteoarthritis and renal disease to sepsis and cardiovascular conditions. The data appears to support a retrospective experience-rated pooled stop-loss insurance model, likely to be used in evaluating health benefit plan performance and potential premium adjustments for the upcoming RFP No. 2130386 for Employee Health Benefits Plan in Florida.

View the file

Other files

File	Type	Posted
Exhibit 50 - Cal Yr 2024 City of Miami CIGNA Vision Plans Claim Summary Report.pdf	PDF	Sep 30, 2025
Exhibit 39 - Cal Yr 2024 City of Miami Stop Loss - High Claimant Report De-ID Dx.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 14b - Cal Yr 2025 City of Miami CIGNA Medicare Benefits - Comp EEs No Rx Plan 70 Percent Ded 300 Max Out Of Pocket 1K ASO69.pdf	PDF	Sep 30, 2025
Questionnaire No. 2 - Stop Loss Insurance.pdf	PDF	Sep 30, 2025
Exhibit 46 - Cal Yr 2025 City of Miami Benefit Eligible Employees as of Sep 2025.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 69 - Cal Yr 2024 City of Miami RX CAP Report Plan Exec Summ and Top 20 Therapeutic Drugs.ppt	PPT presentation	Sep 30, 2025
Exhibit 01a - Cal Yr 2025 YTD as of June City of Miami Monthly Healthcare Detail Experience - Stop Loss ALL claims.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 68 - Cal Yr 2024 City of Miami RX Stats by Ther Class _ Brand Healthcare Spend and Trend.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 57b - Cal Yr 2025 City of Miami YTD as of Apr Stats by Ther Class _ Brand - Healthcare Spend and Trend - Pharmacy - Paid.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 51 - Cal Yr 2023 City of Miami CIGNA Claims by Benefits and ASO Fees Monthly Healthcare Experience by Benefit Option Rolling 12 BenOpt-1.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 52a - Cal Yr 2022 City of Miami CIGNA Pooled Stop Loss High Claims Greater than 50K Experience De-ID.xlsx	XLSX spreadsheet	Sep 30, 2025
Questionnaire No. 7 - Flexible Spending Accounts.pdf	PDF	Sep 30, 2025
Exhibit 06c - Cal Yr 2025 City of Miami CIGNA Dental PPO Certificate Riders and Coverage for other states ETALLD25B Plan 3202272 HC-IMP35.pdf	PDF	Sep 30, 2025
Exhibit 47 - Cal Yr 2023 City of Miami CIGNA Dental Exp.xlsx	XLSX spreadsheet	Sep 30, 2025
Questionnaire No. 5 - Group Benefit Vision Plan.pdf	PDF	Sep 30, 2025
Exhibit 29 - Cal Yr 2025 City of Miami CIGNA OAP No Rx PlanMedical Benefits - Summary Benefits Coverage POST 65.pdf	PDF	Sep 30, 2025
Exhibit 25 - Cal Yr 2025 City of Miami Cobra Monthly Premiums.pdf	PDF	Sep 30, 2025
Exhibit 03 - City of Miami AFSCME 1907 General Employees Union Contract Oct 1 2023 - Sep 30 2026.pdf	PDF	Sep 30, 2025
Exhibit 45 - Cal Yr 2024 City of Miami EAP - EAP Utilization.pptx	PPTX presentation	Sep 30, 2025
Exhibit 05 - Cal Yr 2024 City of Miami CIGNA Dental HMO Plan Document.pdf	PDF	Sep 30, 2025
2130386 - Sample PSA.pdf	PDF	Sep 30, 2025
Exhibit 38 - Cal Yr 2023 City of Miami Stop Loss - Greater than 50K High Claimant Report De-ID Dx.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 44 - Cal Yrs 2025 _ 2026 EAP Renewal Letter.pdf	PDF	Sep 30, 2025
Exhibit 74 - Cal Yr 2023 City of Miami ASO Fixed Charges and Fees Per Product Type Monthly Healthcare Detail Experience.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 37 - Cal Yr 2022 City of Miami Stop Loss - Greater than 50K High Claimant Report De-ID Dx.xlsx	XLSX spreadsheet	Sep 30, 2025
Questionnaire No. 8 - COBRA.pdf	PDF	Sep 30, 2025
Exhibit 55 - Cal Yr 2025 as of Apr EAP Network Analysis Report Access 118974.pdf	PDF	Sep 30, 2025
Exhibit 57c - Cal Yr 2025 YTD as of Jul - City of Miami CIGNA Pharmacy RX Dispensed Report.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 08 - Cal Yr 2024 City of Miami CIGNA EGWP Medicare Formulary.pdf	PDF	Sep 30, 2025
Exhibit 62 - Cal Yr 2025 City of Miami CIGNA FSA Healthcare - Summary Plan Document.pdf	PDF	Sep 30, 2025
Exhibit 16 - Cal Yr 2024 City of Miami CIGNA Open Access Plan (OAP) Medicare No Rx - Comp EEs Plan 80 Percent Ded 500 Max Out of Pocket 2K ASO66.pdf	PDF	Sep 30, 2025
Exhibit 49 - Cal Yr 2023 City of Miami CIGNA Vision Plans Claim Summary Report.pdf	PDF	Sep 30, 2025
Exhibit 54b - Cal Yr 2025 City of Miami Stop CIGNA ISL and ASL Coverage Information Amendment Plan 3202272 CSL-SCH(10-15).pdf	PDF	Sep 30, 2025
Exhibit 34 - Cal Yr 2025 City of Miami CIGNA Dental HMO Summary with Patient Charge Schedule.pdf	PDF	Sep 30, 2025
Exhibit 42 - Cal Yr 2025 City of Miami CIGNA TC19 Disruption Report - Total Records Total Claimants Total Eligible Charges Summary.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 61 - Cal Yr 2025 City of Miami CIGNA FSA Dependent Care - Summary Plan Document.pdf	PDF	Sep 30, 2025
Exhibit 41a - Cal Yr 2025 City of Miami CIGNA Medical - Disruption Detail with Provider TIN - Option 1 - OAP-OA001 RITM9284277_TC19.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 59 - City of Miami CIGNA Medical - Professional Services Agreement AMENDMENT NO 1 May 6 2021 ASO Agreement with Fees.pdf	PDF	Sep 30, 2025
Exhibit 02 - City of Miami AFSCME 871 Sanitation Employees Union Contract Oct 1 2023 - Sep 30 2026.pdf	PDF	Sep 30, 2025
Exhibit 15 - City of Miami Cal Yr 2024 CIGNA Medical - Comp EEs Plan 70 Percent Ded 300 Max Out of Pocket 1K ASO64.pdf	PDF	Sep 30, 2025
Exhibit 30a - Cal Yr 2025 City of MIami CIGNA VIS Vision Benefit imbedded in Medical Plan Document ASO71.pdf	PDF	Sep 30, 2025
Exhibit 18 - Cal Yrs 2023 _ 2024 City of Miami CIGNA FIXED Charges Report - PRR.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 22 - Cal Yr 2025 City of Miami CIGNA Sum Ben Cov Comp EEs No Rx- Out Of Area Plan - Plan 70 Pct Ded 300 Max Out of Pocket 1K ASO67.pdf	PDF	Sep 30, 2025
Attachment A - City of Miami Living Wage Ordinance.pdf	PDF	Sep 30, 2025
Exhibit 19 - Cal Yr 2025 City of Miami CIGNA Medical - SBC Comp Ded 300 Max Out of Pocket 1K.pdf	PDF	Sep 30, 2025
Exhibit 63 - Aug 2024 to Jul 2025 City of Miami CIGNA Claims by Benefits and ASO Fees Monthlty Healthcare Experience by Ben Option Rlg 12.xlsx	XLSX spreadsheet	Sep 30, 2025
Exhibit 17c - Cal Yr 2025 City of Miami CIGNA Healthcare Massachusetts Rider for OAP Plans HC-RDR1.pdf	PDF	Sep 30, 2025
Exhibit 54a - Cal Yr 2025 City of Miami CIGNA Medical - Administrative Services Only ASO And Stop Loss Fees Schedule.pdf	PDF	Sep 30, 2025
Exhibit 05c - Cal Yr 2025 City of Miami CIGNA Dental HMO Certificate Riders and Coverage for 7 States ETALLD25A Plan 3202272 HC-ETRDR.pdf	PDF	Sep 30, 2025
Exhibit 06d - Cal Yr 2025 City of Miami CIGNA Dental PPO Territorial Legislation - 23 States ETALLD25B.pdf	PDF	Sep 30, 2025

Show 40 more

Latest 50 of 114 listed here. See the rest on GovTribe.

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Clms Exc De-ID Dx PYTD-1

CITY OF MIAMI
DE-IDENTIFIED CLAIMS EXCEEDING REPORT
January 2023 thru December 2023
EXHIBIT 52
Rating Type : POOLED STOP LOSS, RETROSPECTIVE EXPERIENCE RATED
Claims Exceeding : $50,000.00
Reported Claims: InNet, OutNet, Drug
Diagnosis is based on the largest medical claim amount
BENEFIT OPTION	BRANCH	FUNDING TYPE	RATING TYPE	REL	GENDER	AGE BAND	ICD CODE	ICD DESCRIPTION	ICD VERSION	DRUG CLAIMS	PAID CLAIMS	CLAIMANT TOTAL
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	50-59	Z0000	ENCNTR FOR GENERAL ADULT MEDICAL EXAM W/O ABNORMAL FINDINGS	10	$99,418	$203	$99,620
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	65+	M1611	UNILATERAL PRIMARY OSTEOARTHRITIS, RIGHT HIP	10	$26,451	$37,836	$64,286
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	EE	M	50-59	N186	END STAGE RENAL DISEASE	10	$16,600	$173,098	$189,698
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	50-59	R0789	OTHER CHEST PAIN	10	$27,832	$25,817	$53,649
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	EE	M	50-59	R9720	ELEVATED PROSTATE SPECIFIC ANTIGEN [PSA]	10	$50,712	$4,595	$55,307
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	60-64	H2510	AGE-RELATED NUCLEAR CATARACT, UNSPECIFIED EYE	10	$2,563	$155	$2,718
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	65+	I4891	UNSPECIFIED ATRIAL FIBRILLATION	10	$19,569	$29,365	$48,934
										$22,131	$29,521	$51,652
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	18-29	N319	NEUROMUSCULAR DYSFUNCTION OF BLADDER, UNSPECIFIED	10	$4,571	$85,618	$90,188
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	EE	M	65+	A4151	SEPSIS DUE TO ESCHERICHIA COLI [E. COLI]	10	$37,344	$229,377	$266,720
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	30-39	E8352	HYPERCALCEMIA	10	$80,177	$371	$80,548
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	EE	M	60-64	I63219	CEREB INFRC DUE TO UNSP OCCLS OR STENOSIS OF UNSP VERTEB ART	10	$0	($1,372)	($1,372)
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NRMC1-NON-MEDICARE RETIREE - 65 W/ DEP - 65	2	R	EE	M	60-64	S066X9A	TRAUM SUBRAC HEM W LOC OF UNSP DURATION, INIT	10	$1,175	$72,818	$73,993
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NRMC1-NON-MEDICARE RETIREE - 65 W/ DEP - 65	2	R	EE	M	65+	I130	HYP HRT & CHR KDNY DIS W HRT FAIL AND STG 1-4/UNSP CHR KDNY	10	$6,432	$5,328	$11,760
										$7,607	$76,774	$84,381
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	1	M	EE	F	40-49	*	UNSPECIFIED	*	$0	$11	$11
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	EE	F	40-49	K51918	ULCERATIVE COLITIS, UNSPECIFIED WITH OTHER COMPLICATION	10	$23,347	$198,638	$221,984
										$23,347	$198,649	$221,995
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	1-17	E230	HYPOPITUITARISM	10	$88,842	$914	$89,756
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	SP	F	50-59	R197	DIARRHEA, UNSPECIFIED	10	$165,361	$3,282	$168,643
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	40-49	Z79899	OTHER LONG TERM (CURRENT) DRUG THERAPY	10	$59,209	$2,844	$62,053
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	18-29	D619	APLASTIC ANEMIA, UNSPECIFIED	10	$114,819	$5,407	$120,226
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	65+	J13	PNEUMONIA DUE TO STREPTOCOCCUS PNEUMONIAE	10	$77,112	$95,473	$172,585
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	40-49	Z1379	ENCNTR FOR OTH SCREENING FOR GENETIC AND CHROMSOML ANOMALIES	10	$12,556	$78,161	$90,717
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	R9439	ABNORMAL RESULT OF OTHER CARDIOVASCULAR FUNCTION STUDY	10	$25,222	$23,923	$49,146
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	60-64	E6601	MORBID (SEVERE) OBESITY DUE TO EXCESS CALORIES	10	$7,662	$94,135	$101,797
										$32,884	$118,058	$150,942
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	50-59	S066X0A	TRAUM SUBRAC HEM W/O LOSS OF CONSCIOUSNESS, INIT	10	$777	$98,613	$99,390
NPOS2-STANDALONE NETWORK POS PLAN COPY NO RX	RMEPDP-RETIRED MEDICARE ELIGIBLE W/PDP PLAN	2	R	EE	M	65+	L89313	PRESSURE ULCER OF RIGHT BUTTOCK, STAGE 3	10	$0	$133,815	$133,815
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	EE	F	50-59	S199XXA	UNSPECIFIED INJURY OF NECK, INITIAL ENCOUNTER	10	$0	($706)	($706)
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	EE	F	60-64	I25110	ATHSCL HEART DISEASE OF NATIVE COR ART W UNSTABLE ANG PCTRS	10	$3,443	$19,300	$22,742
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NRSEA1-NON-MEDICARE RETIREE - 65 W/ DEP - 65	2	R	EE	F	60-64	M1612	UNILATERAL PRIMARY OSTEOARTHRITIS, LEFT HIP	10	$8,937	$79,356	$88,293
										$12,379	$97,950	$110,329
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	CH	M	<-1	Z3801	SINGLE LIVEBORN INFANT, DELIVERED BY CESAREAN	10	$1,562	$48,594	$50,156
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	EE	M	40-49	B20	HUMAN IMMUNODEFICIENCY VIRUS [HIV] DISEASE	10	$50,456	$1,571	$52,027
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	CH	M	1-17	E049	NONTOXIC GOITER, UNSPECIFIED	10	$115,190	$2,347	$117,537
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	SP	F	50-59	K651	PERITONEAL ABSCESS	10	$77,530	$20,523	$98,053
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	50-59	I340	NONRHEUMATIC MITRAL (VALVE) INSUFFICIENCY	10	$6,083	$119,162	$125,245
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	H2511	AGE-RELATED NUCLEAR CATARACT, RIGHT EYE	10	$4,207	$22,910	$27,117
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	60-64	T8522XA	DISPLACEMENT OF INTRAOCULAR LENS, INITIAL ENCOUNTER	10	$11,099	$23,600	$34,698
										$15,305	$46,510	$61,815
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	EE	M	50-59	Z0001	ENCOUNTER FOR GENERAL ADULT MEDICAL EXAM W ABNORMAL FINDINGS	10	$0	$42	$42
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	E559	VITAMIN D DEFICIENCY, UNSPECIFIED	10	$68,571	$2,080	$70,651
										$68,571	$2,122	$70,693
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	65+	N2889	OTHER SPECIFIED DISORDERS OF KIDNEY AND URETER	10	$434	$53,058	$53,492
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	60-64	R269	UNSPECIFIED ABNORMALITIES OF GAIT AND MOBILITY	10	$0	$80	$80
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	65+	I472	VENTRICULAR TACHYCARDIA	10	$22,493	$105,699	$128,192
										$22,493	$105,778	$128,271
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	65+	T8361XA	I/I REACT D/T IMPLANTED PENILE PROSTHESIS, INITIAL ENCOUNTER	10	$332	$117,940	$118,271
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	EE	M	50-59	M00262	OTHER STREPTOCOCCAL ARTHRITIS, LEFT KNEE	10	$4,586	$51,459	$56,045
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	50-59	Z5111	ENCOUNTER FOR ANTINEOPLASTIC CHEMOTHERAPY	10	$1,034	$227,722	$228,756
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	50-59	C50112	MALIGNANT NEOPLASM OF CENTRAL PORTION OF LEFT FEMALE BREAST	10	$28	$123,343	$123,371
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	30-39	M1612	UNILATERAL PRIMARY OSTEOARTHRITIS, LEFT HIP	10	$0	$96	$96
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	40-49	M1612	UNILATERAL PRIMARY OSTEOARTHRITIS, LEFT HIP	10	$3,374	$59,753	$63,127
										$3,374	$59,849	$63,223
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	65+	M0579	RHEU ARTHRITIS W RHEU FACTOR MULT SITE W/O ORG/SYS INVOLV	10	$41,216	$9,093	$50,309
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	50-59	M4712	OTHER SPONDYLOSIS WITH MYELOPATHY, CERVICAL REGION	10	$189	$50,063	$50,251
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	50-59	PH	PHARMACY	*	$5,462	$0	$5,462
										$5,651	$50,063	$55,714
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	F	18-29	E1010	TYPE 1 DIABETES MELLITUS WITH KETOACIDOSIS WITHOUT COMA	10	$6,786	$79,418	$86,204
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	SP	M	50-59	*	UNSPECIFIED	*	$0	$3,171	$3,171
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	50-59	T8640	UNSPECIFIED COMPLICATION OF LIVER TRANSPLANT	10	$24,686	$23,369	$48,054
										$24,686	$26,540	$51,226
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	40-49	T8469XA	INFECT/INFLM REACTION DUE TO INT FIX OF SITE, INIT	10	$289	$78,204	$78,493
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	40-49	E6601	MORBID (SEVERE) OBESITY DUE TO EXCESS CALORIES	10	$471	$60,477	$60,949
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	H2511	AGE-RELATED NUCLEAR CATARACT, RIGHT EYE	10	$45,197	$34,961	$80,158
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	CH	F	18-29	*	UNSPECIFIED	*	$0	$293,299	$293,299
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	F	18-29	T8621	HEART TRANSPLANT REJECTION	10	$15,625	$334,631	$350,256
										$15,625	$627,930	$643,555
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	50-59	K3532	AC APPENDICITIS W PERF, LOC PERITONITIS, & GANGR, W/O ABSCS	10	$122,529	$109,658	$232,187
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	40-49	K50118	CROHN'S DISEASE OF LARGE INTESTINE WITH OTHER COMPLICATION	10	$1,788	$102,892	$104,680
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	<-1	P220	RESPIRATORY DISTRESS SYNDROME OF NEWBORN	10	$0	$186,624	$186,624
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	CH	M	<-1	*	UNSPECIFIED	*	$0	$520,680	$520,680
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	CH	M	1-17	*	UNSPECIFIED	*	$0	$510	$510
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	<-1	Z3831	TWIN LIVEBORN INFANT, DELIVERED BY CESAREAN	10	$576	$162,800	$163,376
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	1-17	Z00129	ENCNTR FOR ROUTINE CHILD HEALTH EXAM W/O ABNORMAL FINDINGS	10	$0	$0	$0
										$576	$870,614	$871,190
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	30-39	G129	SPINAL MUSCULAR ATROPHY, UNSPECIFIED	10	$0	$108,615	$108,615
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	18-29	S270XXA	TRAUMATIC PNEUMOTHORAX, INITIAL ENCOUNTER	10	$0	$63,061	$63,061
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65	2	R	CH	F	18-29	S82873A	DISPLACED PILON FRACTURE OF UNSP TIBIA, INIT FOR CLOS FX	10	$596	$70,350	$70,946
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	SP	F	50-59	Z0000	ENCNTR FOR GENERAL ADULT MEDICAL EXAM W/O ABNORMAL FINDINGS	10	$0	$42	$42
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	50-59	R197	DIARRHEA, UNSPECIFIED	10	$60,575	$19,160	$79,735
										$60,575	$19,202	$79,777
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	30-39	E6601	MORBID (SEVERE) OBESITY DUE TO EXCESS CALORIES	10	$1,279	$77,971	$79,250
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	40-49	R42	DIZZINESS AND GIDDINESS	10	$8,678	$84,321	$92,999
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	65+	I2510	ATHSCL HEART DISEASE OF NATIVE CORONARY ARTERY W/O ANG PCTRS	10	$99,759	$236,096	$335,855
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	40-49	I671	CEREBRAL ANEURYSM, NONRUPTURED	10	$137,084	$13,528	$150,612
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	60-64	D0511	INTRADUCTAL CARCINOMA IN SITU OF RIGHT BREAST	10	$16,945	$28,600	$45,545
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	65+	Z9011	ACQUIRED ABSENCE OF RIGHT BREAST AND NIPPLE	10	$63,917	$2,113	$66,030
										$80,862	$30,713	$111,575
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	40-49	R69	ILLNESS, UNSPECIFIED	10	$249	$50,910	$51,158
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	50-59	Z5111	ENCOUNTER FOR ANTINEOPLASTIC CHEMOTHERAPY	10	$5,716	$98,841	$104,557
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	60-64	PH	PHARMACY	*	$191	$0	$191
										$5,907	$98,841	$104,748
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	EE	F	50-59	*	UNSPECIFIED	*	$0	$279,952	$279,952
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	50-59	D61810	ANTINEOPLASTIC CHEMOTHERAPY INDUCED PANCYTOPENIA	10	$2,779	$347,863	$350,642
										$2,779	$627,815	$630,594
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	18-29	S36430A	LACERATION OF DUODENUM, INITIAL ENCOUNTER	10	$22	$225,732	$225,754
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	60-64	R0789	OTHER CHEST PAIN	10	$53,983	$4,158	$58,141
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	EE	M	30-39	M50223	OTHER CERVICAL DISC DISPLACEMENT AT C6-C7 LEVEL	10	$248	$61,639	$61,887
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	EE	M	60-64	D649	ANEMIA, UNSPECIFIED	10	$0	$32	$32
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	EE	M	65+	C61	MALIGNANT NEOPLASM OF PROSTATE	10	$15,621	$180,319	$195,940
										$15,621	$180,352	$195,972
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	50-59	I214	NON-ST ELEVATION (NSTEMI) MYOCARDIAL INFARCTION	10	$9,043	$67,919	$76,962
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	18-29	K5190	ULCERATIVE COLITIS, UNSPECIFIED, WITHOUT COMPLICATIONS	10	$105,454	$2,007	$107,461
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	EE	M	60-64	*	UNSPECIFIED	*	$0	$387,658	$387,658
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	60-64	Z5112	ENCOUNTER FOR ANTINEOPLASTIC IMMUNOTHERAPY	10	$105,431	$233,293	$338,724
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	65+	R0602	SHORTNESS OF BREATH	10	$226	$157	$383
										$105,657	$621,108	$726,765
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	EE	M	60-64	C8510	UNSPECIFIED B-CELL LYMPHOMA, UNSPECIFIED SITE	10	$101,873	$28,131	$130,004
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	EE	M	30-39	*	UNSPECIFIED	*	$0	$1,015	$1,015
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	30-39	K5150	LEFT SIDED COLITIS WITHOUT COMPLICATIONS	10	$331,114	$18,887	$350,000
										$331,114	$19,902	$351,015
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	40-49	R0789	OTHER CHEST PAIN	10	$822	$100,778	$101,600
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	50-59	N200	CALCULUS OF KIDNEY	10	$62,917	$25,756	$88,673
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	SP	F	40-49	K5000	CROHN'S DISEASE OF SMALL INTESTINE WITHOUT COMPLICATIONS	10	$4,553	$36,699	$41,252
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	SP	M	40-49	PH	PHARMACY	*	$55,526	$0	$55,526
										$60,079	$36,699	$96,777
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	40-49	PH	PHARMACY	*	$1,755	$0	$1,755
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	40-49	J020	STREPTOCOCCAL PHARYNGITIS	10	$47,764	$20,457	$68,221
										$49,519	$20,457	$69,976
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	40-49	G35	MULTIPLE SCLEROSIS	10	$92,126	$6,220	$98,346
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	SP	F	50-59	I214	NON-ST ELEVATION (NSTEMI) MYOCARDIAL INFARCTION	10	$2,538	$114,624	$117,162
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	40-49	N186	END STAGE RENAL DISEASE	10	$6,221	$94,666	$100,886
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	EE	F	30-39	N72	INFLAMMATORY DISEASE OF CERVIX UTERI	10	$7,940	$42,689	$50,629
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	40-49	G35	MULTIPLE SCLEROSIS	10	$2,101	$182,390	$184,490
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	60-64	N812	INCOMPLETE UTEROVAGINAL PROLAPSE	10	$2,662	$57,862	$60,524
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	EE	M	65+	I441	ATRIOVENTRICULAR BLOCK, SECOND DEGREE	10	$1,955	$70,083	$72,038
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	F	<-1	P220	RESPIRATORY DISTRESS SYNDROME OF NEWBORN	10	$0	$319,188	$319,188
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	CH	F	<-1	*	UNSPECIFIED	*	$0	$690,565	$690,565
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	CH	F	1-17	*	UNSPECIFIED	*	$0	$512	$512
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	F	<-1	Z3831	TWIN LIVEBORN INFANT, DELIVERED BY CESAREAN	10	$812	$29,999	$30,812
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	F	1-17	Z00129	ENCNTR FOR ROUTINE CHILD HEALTH EXAM W/O ABNORMAL FINDINGS	10	$0	$0	$0
										$812	$1,040,264	$1,041,076
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	MRG1-MEDICARE RETIREE 65+ W/ DEP UNDER 65	2	R	EE	F	60-64	C569	MALIGNANT NEOPLASM OF UNSPECIFIED OVARY	10	$599	$202,349	$202,948
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	MRG1-MEDICARE RETIREE 65+ W/ DEP UNDER 65	2	R	EE	F	65+	C772	SECONDARY AND UNSP MALIGNANT NEOPLASM OF INTRA-ABD NODES	10	$18,397	$36,764	$55,160
										$18,996	$239,113	$258,109
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	SP	F	30-39	O99891	OTH DISEASES AND CONDITIONS COMPLICATING PREGNANCY	10	$31	$66,588	$66,619
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	EE	F	50-59	*	UNSPECIFIED	*	$0	$371,949	$371,949
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	50-59	Z5112	ENCOUNTER FOR ANTINEOPLASTIC IMMUNOTHERAPY	10	$2,703	$346,642	$349,345
										$2,703	$718,590	$721,293
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65	1	M	EE	M	60-64	*	UNSPECIFIED	*	$0	$24,320	$24,320
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65	2	R	EE	M	60-64	I110	HYPERTENSIVE HEART DISEASE WITH HEART FAILURE	10	$606	$349,042	$349,648
										$606	$373,363	$373,969
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	40-49	D250	SUBMUCOUS LEIOMYOMA OF UTERUS	10	$2,632	$54,306	$56,939
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	EE	F	60-64	R110	NAUSEA	10	$102,224	$7,789	$110,013
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	18-29	D5700	HB-SS DISEASE WITH CRISIS, UNSPECIFIED	10	$123	$52,980	$53,103
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	SP	M	65+	*	UNSPECIFIED	*	$0	$515,871	$515,871
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	65+	Z5111	ENCOUNTER FOR ANTINEOPLASTIC CHEMOTHERAPY	10	$5,951	$341,070	$347,021
										$5,951	$856,941	$862,892
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	EE	M	65+	N400	BENIGN PROSTATIC HYPERPLASIA WITHOUT LOWER URINRY TRACT SYMP	10	$637	$54,662	$55,299
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	C61	MALIGNANT NEOPLASM OF PROSTATE	10	$143	$77,759	$77,902
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	60-64	N529	MALE ERECTILE DYSFUNCTION, UNSPECIFIED	10	$59	$150	$209
										$202	$77,908	$78,111
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	F	1-17	B003	HERPESVIRAL MENINGITIS	10	$0	$103,809	$103,809
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	50-59	J339	NASAL POLYP, UNSPECIFIED	10	$54,994	$1,948	$56,942
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65	2	R	SP	M	60-64	M48062	SPINAL STENOSIS, LUMBAR REGION WITH NEUROGENIC CLAUDICATION	10	$664	$52,887	$53,551
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NASEA-ACTIVE EMPLOYEES (SEA)	2	R	EE	F	40-49	M3214	GLOMERULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS	10	$4,612	$170,493	$175,105
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	65+	I4820	CHRONIC ATRIAL FIBRILLATION, UNSPECIFIED	10	$12,571	$165,108	$177,679
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	60-64	I214	NON-ST ELEVATION (NSTEMI) MYOCARDIAL INFARCTION	10	$709	$65,385	$66,094
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	40-49	K6289	OTHER SPECIFIED DISEASES OF ANUS AND RECTUM	10	$9,519	$53,725	$63,244
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	M5450	LOW BACK PAIN, UNSPECIFIED	10	$57,199	$2,344	$59,543
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	40-49	C182	MALIGNANT NEOPLASM OF ASCENDING COLON	10	$6,689	$30,505	$37,193
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	I2109	STEMI INVOLVING OTH CORONARY ARTERY OF ANTERIOR WALL	10	$5,105	$60,581	$65,686
										$11,794	$91,086	$102,879
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	EE	F	60-64	*	UNSPECIFIED	*	$0	$23,947	$23,947
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	60-64	Z5112	ENCOUNTER FOR ANTINEOPLASTIC IMMUNOTHERAPY	10	$7,803	$342,093	$349,896
										$7,803	$366,040	$373,843
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	SP	F	50-59	*	UNSPECIFIED	*	$0	$157,899	$157,899
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	50-59	Z5111	ENCOUNTER FOR ANTINEOPLASTIC CHEMOTHERAPY	10	$559	$350,042	$350,601
										$559	$507,941	$508,500
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	30-39	E6601	MORBID (SEVERE) OBESITY DUE TO EXCESS CALORIES	10	$19,313	$45,686	$65,000
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	50-59	I2510	ATHSCL HEART DISEASE OF NATIVE CORONARY ARTERY W/O ANG PCTRS	10	$9,989	$68,939	$78,928
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	60-64	N281	CYST OF KIDNEY, ACQUIRED	10	$2,280	$202	$2,482
										$12,269	$69,141	$81,410
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	50-59	C50411	MALIG NEOPLM OF UPPER-OUTER QUADRANT OF RIGHT FEMALE BREAST	10	$6,668	$94,416	$101,085
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	30-39	U071	COVID-19	10	$57,457	$660	$58,118
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	65+	Z510	ENCOUNTER FOR ANTINEOPLASTIC RADIATION THERAPY	10	$12,864	$119,345	$132,209
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	I69351	HEMIPLGA FOLLOWING CEREBRAL INFRC AFF RIGHT DOMINANT SIDE	10	$22,723	$61,537	$84,260
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	65+	R519	HEADACHE, UNSPECIFIED	10	$87,139	$9,483	$96,623
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	30-39	J4550	SEVERE PERSISTENT ASTHMA, UNCOMPLICATED	10	$55,282	$456	$55,738
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65	2	R	EE	F	60-64	N186	END STAGE RENAL DISEASE	10	$20,493	$85,046	$105,539
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	CH	F	1-17	*	UNSPECIFIED	*	$0	$131	$131
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	F	1-17	R2689	OTHER ABNORMALITIES OF GAIT AND MOBILITY	10	$332,680	$11,305	$343,985
										$332,680	$11,436	$344,116
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	CH	F	1-17	M41127	ADOLESCENT IDIOPATHIC SCOLIOSIS, LUMBOSACRAL REGION	10	$0	$217,086	$217,086
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	CH	F	18-29	H04123	DRY EYE SYNDROME OF BILATERAL LACRIMAL GLANDS	10	$17	$141	$158
										$17	$217,227	$217,244
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	50-59	I63511	CEREB INFRC D/T UNSP OCCLS OR STENOS OF RIGHT MID CEREB ART	10	$398	$110,969	$111,367
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	CH	F	18-29	K5000	CROHN'S DISEASE OF SMALL INTESTINE WITHOUT COMPLICATIONS	10	$328,133	$7,240	$335,373
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	18-29	G35	MULTIPLE SCLEROSIS	10	$76,411	$560	$76,971
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	SP	F	40-49	K5100	ULCERATIVE (CHRONIC) PANCOLITIS WITHOUT COMPLICATIONS	10	$162,281	$9,743	$172,024
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	SP	M	50-59	I63412	CEREB INFRC DUE TO EMBOLISM OF LEFT MIDDLE CEREBRAL ARTERY	10	$8,067	$120,275	$128,342
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	40-49	C50411	MALIG NEOPLM OF UPPER-OUTER QUADRANT OF RIGHT FEMALE BREAST	10	$3,301	$320,287	$323,588
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	I214	NON-ST ELEVATION (NSTEMI) MYOCARDIAL INFARCTION	10	$2,943	$75,000	$77,944
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	EE	F	60-64	*	UNSPECIFIED	*	$0	$25,355	$25,355
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	60-64	K635	POLYP OF COLON	10	$239,651	($17,553)	$222,098
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	65+	M85852	OTH DISRD OF BONE DENSITY AND STRUCTURE, LEFT THIGH	10	$92,044	$1,217	$93,261
										$331,695	$9,018	$340,713
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	E10621	TYPE 1 DIABETES MELLITUS WITH FOOT ULCER	10	$2,914	$229,489	$232,403
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	E1211-EXECUTIVES/ELECTED OFFICIALS	2	R	CH	M	1-17	K5090	CROHN'S DISEASE, UNSPECIFIED, WITHOUT COMPLICATIONS	10	$64,666	$30,733	$95,399
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	EE	M	18-29	E1165	TYPE 2 DIABETES MELLITUS WITH HYPERGLYCEMIA	10	$8,349	$43,047	$51,396
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	60-64	C786	SECONDARY MALIGNANT NEOPLASM OF RETROPERITON AND PERITONEUM	10	$2,306	$68,765	$71,072
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	C182	MALIGNANT NEOPLASM OF ASCENDING COLON	10	$9,020	$66,031	$75,051
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	F	40-49	C50912	MALIGNANT NEOPLASM OF UNSPECIFIED SITE OF LEFT FEMALE BREAST	10	$2,994	$59,624	$62,617
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	EE	M	40-49	*	UNSPECIFIED	*	$0	$6,103	$6,103
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	1	M	EE	M	50-59	*	UNSPECIFIED	*	$0	$380,121	$380,121
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	40-49	I480	PAROXYSMAL ATRIAL FIBRILLATION	10	$1,526	$331,215	$332,741
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	50-59	L03115	CELLULITIS OF RIGHT LOWER LIMB	10	$23,949	($6,887)	$17,062
										$25,476	$710,551	$736,026
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	40-49	S069X0A	UNSP INTRACRANIAL INJURY W/O LOSS OF CONSCIOUSNESS, INIT	10	$4,055	$59,317	$63,371
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	18-29	M329	SYSTEMIC LUPUS ERYTHEMATOSUS, UNSPECIFIED	10	$327	$1,659	$1,987
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	30-39	M328	OTHER FORMS OF SYSTEMIC LUPUS ERYTHEMATOSUS	10	$493	$133,432	$133,925
										$821	$135,091	$135,912
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	18-29	K5000	CROHN'S DISEASE OF SMALL INTESTINE WITHOUT COMPLICATIONS	10	$90,584	$164	$90,748
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	40-49	I4720	VENTRICULAR TACHYCARDIA, UNSPECIFIED	10	$21,437	$57,284	$78,722
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	M	60-64	M542	CERVICALGIA	10	$69,878	$13,627	$83,505
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	EE	F	60-64	K8042	CALCULUS OF BILE DUCT W ACUTE CHOLECYSTITIS W/O OBSTRUCTION	10	$811	$50,366	$51,177
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	CH	M	<-1	Z3800	SINGLE LIVEBORN INFANT, DELIVERED VAGINALLY	10	$0	$110,825	$110,825
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAMC-ACTIVE EMPLOYEES (M/C)	2	R	CH	M	<-1	Q673	PLAGIOCEPHALY	10	$0	$6,140	$6,140
										$0	$116,965	$116,965
NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES)	NAGEN-ACTIVE EMPLOYEES (GENERAL)	2	R	SP	M	60-64	N186	END STAGE RENAL DISEASE	10	$310	$108,273	$108,583

Grand Total $5,140,680 $16,210,917 $21,351,597

&G &7This report contains proprietary and/or confidential information. Disclosure is strictly prohibited except to the extent required by law. ADVICE Reporting System &8Page &P of &N Date: 4/8/2025

&7Cigna makes no warranty, express or implied, as to content and disclaims all liability arising directly or indirectly from use or reliance upon its contents by any third party even if Cigna has been advised of an intended use.

image1.png

File details come from the government source that posted it. Updated Oct 9, 2025.